Use of Favipiravir in treatment of COVID-19 | Indian Phase 3 Clinical Trial Outcomes
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was declared a global pandemic in March 2020 by the WHO. During the time since it emerged into a global crisis, there have been several recommendations to prevent spread of infection and to manage COVID-19 infected patients through supportive care, plasma...
Sagar Panchal
Indian Medical Association-MS (IMA - MS)
Therapeutic
DR. SAGAR S. PANCHAL M.B.B.S, M.D (Pharmacology) SYNOPSIS Pharmaceutical physician by profession with strong academic & clinical background. Currently working as Medical advisor in Respiratory division of Glenmark Pharmaceuticals. Organized, efficient, reliable professional with proven... View Detail
Swami Digambar Pawar
Indian Medical Association-MS (IMA - MS)
Therapeutic
DR. SWAMI DIGAMBAR PAWAR EDUCATIONAL QUALIFICATION: MD Chest- Grant Medical College, Mumbai MBBS- G. S. Medical College, Mumbai MEMBERSHIPS: Life Member of Critical Care Foundation & College of Critical Care Medicine, India. Member American... View Detail
Swapnil Gautam
Indian Medical Association-MS (IMA - MS)
Therapeutic
DR. SWAPNIL GAUTAM MBBS, MD, DNB, MNAMS, PGDMLS, MRCP(London),MRCP(Edinburgh),MRCPS(Glasgow) PGDip Infectious Disease( University of New South Wales, Sydney) PGDip Infectious Disease( University of London ) ... View Detail
Pankaj Bandarkar
Indian Medical Association-MS (IMA - MS)
Therapeutic
Dr Pankaj Bandarkar Family Physician Hon. State secretary, IMA MS View Detail